These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9070725)

  • 1. Danazol administration after gonadotrophin-releasing hormone analogue reduces rebound of uterine myomas.
    De Leo V; Morgante G; Lanzetta D; D'Antona D; Bertieri RS
    Hum Reprod; 1997 Feb; 12(2):357-60. PubMed ID: 9070725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term treatment of uterine fibromyomas with danazol.
    De Leo V; la Marca A; Morgante G
    Gynecol Obstet Invest; 1999; 47(4):258-62. PubMed ID: 10352389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix.
    Gonzalez-Barcena D; Alvarez RB; Ochoa EP; Cornejo IC; Comaru-Schally AM; Schally AV; Engel J; Reissmann T; Riethmüller-Winzen H
    Hum Reprod; 1997 Sep; 12(9):2028-35. PubMed ID: 9363724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocrinological and histological changes after treatment of uterine leiomyomas with danazol or buserelin.
    Ueki M; Okamoto Y; Tsurunaga T; Seiki Y; Ueda M; Sugimoto O
    J Obstet Gynaecol (Tokyo 1995); 1995 Feb; 21(1):1-7. PubMed ID: 8591104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of uterine leiomyomata in response to the antiprogesterone RU 486.
    Murphy AA; Kettel LM; Morales AJ; Roberts VJ; Yen SS
    J Clin Endocrinol Metab; 1993 Feb; 76(2):513-7. PubMed ID: 8432797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotrophin hormone-releasing hormone analogue treatment of fibroids.
    Shaw RW
    Baillieres Clin Obstet Gynaecol; 1998 Jun; 12(2):245-68. PubMed ID: 10023421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of preoperative medical treatment in facilitating hysteroscopic endometrial resection, myomectomy and metroplasty: literature review.
    Parazzini F; Vercellini P; De Giorgi O; Pesole A; Ricci E; Crosignani PG
    Hum Reprod; 1998 Sep; 13(9):2592-7. PubMed ID: 9806290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
    Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of perimenopausal women with uterine myoma: successful use of a depot GnRH agonist leading to a natural menopause.
    Imai A; Sugiyama M; Furui T; Tamaya T
    J Obstet Gynaecol; 2003 Sep; 23(5):518-20. PubMed ID: 12963511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between hormone receptor concentration and tumor shrinkage in uterine myoma after treatment with a GnRHa.
    Wang PH; Lee WL; Chao HT; Shu LP; Kao HL; Wu CW; Yuan CC
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 May; 62(5):294-9. PubMed ID: 10389284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GnRH analogues in the treatment of uterine fibroids.
    Golan A
    Hum Reprod; 1996 Nov; 11 Suppl 3():33-41. PubMed ID: 9147100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
    Lethaby A; Vollenhoven B; Sowter M
    Cochrane Database Syst Rev; 2000; (2):CD000547. PubMed ID: 10796723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
    Tan YH; Lethaby A
    Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-surgical treatment of uterine myomas with LH-RH agonists.
    D'Addato F; Repinto A; Andreoli C
    Clin Exp Obstet Gynecol; 1992; 19(1):45-50. PubMed ID: 1535032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestins and uterine leiomyoma.
    Schweppe KW
    Gynecol Endocrinol; 1999 Jun; 13 Suppl 4():21-4. PubMed ID: 12227898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
    Lethaby AE; Vollenhoven BJ
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):307-31. PubMed ID: 17905660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Danazol for uterine fibroids.
    Ke LQ; Yang K; Li J; Li CM
    Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007692. PubMed ID: 19588442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin-releasing hormone agonist therapy induces apoptosis in uterine leiomyoma.
    Higashijima T; Kataoka A; Nishida T; Yakushiji M
    Eur J Obstet Gynecol Reprod Biol; 1996 Sep; 68(1-2):169-73. PubMed ID: 8886702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid reduction of uterine myomas after short-term treatment with microencapsulated D-Trp6-LHRH.
    van Leusden HA
    Lancet; 1986 Nov; 2(8517):1213. PubMed ID: 2877341
    [No Abstract]   [Full Text] [Related]  

  • 20. Medical management of fibroids.
    Sankaran S; Manyonda IT
    Best Pract Res Clin Obstet Gynaecol; 2008 Aug; 22(4):655-76. PubMed ID: 18468953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.